NanoCarrier Co. Ltd
Nano Holdings, Inc. researches, develops, produces, and sells pharmaceuticals using micellar nanoparticles technology in Japan. The company's pipeline products include RUNX1 (mRNA) for the treatment knee osteoarthritis and reduces pain; and NC-6100 PRDM14 (siRNA), which is in phase I clinical trials for the treatment of breast cancer. Its product pipeline also comprises TUG1 (ASO) for glioblastom… Read more
NanoCarrier Co. Ltd - Asset Resilience Ratio
NanoCarrier Co. Ltd (3NQ) has an Asset Resilience Ratio of 50.31% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2025)
This chart shows how NanoCarrier Co. Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down NanoCarrier Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €1.70 Billion | 50.31% |
| Total Liquid Assets | €1.70 Billion | 50.31% |
Asset Resilience Insights
- Very High Liquidity: NanoCarrier Co. Ltd maintains exceptional liquid asset reserves at 50.31% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
NanoCarrier Co. Ltd Industry Peers by Asset Resilience Ratio
Compare NanoCarrier Co. Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
MedPacto Inc
KQ:235980 |
Biotechnology | 49.82% |
|
Shenzhen CAU Technology Co Ltd
SHE:000004 |
Biotechnology | 6.20% |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 |
Biotechnology | 6.88% |
|
Nanhua Bio Medicine Co Ltd
SHE:000504 |
Biotechnology | 11.93% |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
Biotechnology | 0.03% |
|
Chengzhi Shareholding Co Ltd
SHE:000990 |
Biotechnology | 6.73% |
|
Hualan Biological EngineeringInc
SHE:002007 |
Biotechnology | 14.68% |
|
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 |
Biotechnology | 4.35% |
Annual Asset Resilience Ratio for NanoCarrier Co. Ltd (2014–2025)
The table below shows the annual Asset Resilience Ratio data for NanoCarrier Co. Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 44.99% | €1.80 Billion | €4.00 Billion | +1.61pp |
| 2024-03-31 | 43.38% | €2.20 Billion | €5.07 Billion | +15.17pp |
| 2023-03-31 | 28.22% | €1.63 Billion | €5.78 Billion | -5.42pp |
| 2022-03-31 | 33.63% | €2.40 Billion | €7.14 Billion | +1.53pp |
| 2021-03-31 | 32.10% | €2.51 Billion | €7.82 Billion | -1.44pp |
| 2020-03-31 | 33.54% | €3.00 Billion | €8.94 Billion | +10.20pp |
| 2019-03-31 | 23.34% | €2.00 Billion | €8.57 Billion | -12.30pp |
| 2018-03-31 | 35.65% | €2.72 Billion | €7.63 Billion | +17.30pp |
| 2017-03-31 | 18.35% | €2.37 Billion | €12.94 Billion | +7.43pp |
| 2016-03-31 | 10.91% | €1.68 Billion | €15.39 Billion | +10.20pp |
| 2015-03-31 | 0.71% | €105.00 Million | €14.70 Billion | -0.02pp |
| 2014-03-31 | 0.73% | €105.00 Million | €14.34 Billion | -- |